Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Uveal Melanoma × Diet Therapy × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 11 Breast Neoplasms 11 Obesity 7 Motor Activity 5 Malnutrition 5 Colorectal Neoplasms 5 Polycystic Ovary Syndrome 4 Pancreatic Neoplasms 3 Overweight 3 Ovarian Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Gastrointestinal Neoplasms 3 Weight Loss 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Multiple Myeloma 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Insulin Resistance 2 Head and Neck Neoplasms 2 Glioblastoma 2 Fatigue 2 Endometrial Neoplasms 2 Cachexia 2 Burkitt Lymphoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1

Interventions

Ipilimumab 14 Nivolumab 12 incomplete Freund's adjuvant 8 Cyclophosphamide 7 pembrolizumab 6 Ranibizumab 6 CTLA-4 Antigen 6 sargramostim 5 Radiosurgery 5 Blood Specimen Collection 5 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 MART-1 Antigen 4 Biopsy 4 tebentafusp 3 aflibercept 3 Temozolomide 3 Sunitinib 3 Specimen Handling 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Bevacizumab 3 130-nm albumin-bound paclitaxel 3 olaparib 2 montanide ISA 51 2 lenvatinib 2 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Triamcinolone Acetonide 2 Thalidomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04645680 2026-01-30

DIET

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡